Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-25-005404
Filing Date
2025-08-14
Accepted
2025-08-14 07:30:17
Documents
53
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K evax20250806_6k.htm   iXBRL 6-K 24004
2 EXHIBIT 99.1 ex_848977.htm   iXBRL EX-99.1 742168
3 EXHIBIT 99.2 ex_848978.htm EX-99.2 166623
  Complete submission text file 0001171843-25-005404.txt   3978817

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA evax-20250630.xsd EX-101.SCH 43070
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evax-20250630_cal.xml EX-101.CAL 33034
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evax-20250630_def.xml EX-101.DEF 273783
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE evax-20250630_lab.xml EX-101.LAB 219675
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evax-20250630_pre.xml EX-101.PRE 283751
56 EXTRACTED XBRL INSTANCE DOCUMENT evax20250806_6k_htm.xml XML 609602
Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM Denmark
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM Denmark 4552656554
Evaxion A/S (Filer) CIK: 0001828253 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 251214347
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)